A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.
A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.
Many Hope & Cope volunteers were troubled by not being allowed to see cancer patients in person during the pandemic, but now those ties are being re-established.
As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.
Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.
Although radiation therapy for cancer must be administered in person, the Division of Radiation Oncology is making extensive use of telehealth to provide support to patients and keep staff in the loop.
JGH nurses in many fields are playing a key role in using telehealth to maintain contact with patients and provide the support they need at home.
A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.
A JGH nursing initiative to help cancer outpatients manage their symptoms more effectively has won an award from the Order of Nurses of Quebec.